Pictet Asset Management Sa Bluebird Bio, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 4,666,813 shares of BLUE stock, worth $28.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,666,813
Previous 3,104,751
50.31%
Holding current value
$28.2 Million
Previous $9.87 Million
55.5%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BLUE
# of Institutions
67Shares Held
39.7MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$93.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.84MShares$23.2 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.63MShares$9.85 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.61MShares$9.72 Million0.0% of portfolio
-
Lion Point Capital, LP New York, NY1.58MShares$9.53 Million2.2% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $466M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...